2026 Prompts

Neuroscience

The human brain is increasingly interacting with technology at an unprecedented rate. Rapid advancements in Brain-Computer Interfaces (BCIs) among other neuromonitoring technologies allow scientists to record and decode neural signals with high accuracy. While these tools offer valuable diagnostics and treatments for various neurological disorders, they also generate personal biometric data, which blurs the line between biological processes and digital information.

What makes gathering neural data unique compared to other biological data, and what are the implications of developing and commercializing neurotechnology?

Here are some questions to help guide your writing:

How does the process of reading brainwaves (EEGs, implantations) differ from taking a set of vitals?
How should policymakers regulate the collection, storage, and commercialization of neural data?
Is recording an individual’s attention or emotion different than taking physiological biometrics?
Are ethical rules the same when a BCI serves as a medical device (for treatment of neurological disease) compared to a commercial gadget?
As states such as Colorado and California have passed consumer privacy acts to protect neural data, how should we define cognitive privacy? Should any cognitive data be protected as a fundamental right, or should privacy be protected only to a certain limit?

Synthetic Biology

The rise of antimicrobial resistance (AMR) is one of the most serious challenges facing modern medicine, with superbugs increasingly rendering even the strongest antibiotics impotent. As standard drugs fail, researchers are looking towards a century-old concept using synthetic biology: phage therapy. Bacteriophages, which are viruses that naturally target and destroy specific bacteria without harming human cells, are now being genetically engineered to bypass bacterial defenses. This innovation means that synthetic virology offers a radical alternative to broad-spectrum antibiotics, whilst also changing our understanding and relationship with the viral world.

Can synthetic phage therapy successfully replace antibiotics on a global scale, and what are the evolutionary and regulatory risks of deploying engineered viruses?

Here are some questions to help guide your writing:

How do bacteriophages attack bacteria, and what molecular engineering techniques are used to modify these viruses to target antibiotic-resistant strains?
Unlike static chemical drugs, phages co-evolve with their hosts. How might bacteria develop resistance to phage therapy, and how can scientists anticipate this evolutionary arms race?
What are the logistical and financial hurdles of manufacturing and storing live biological viruses for widespread clinical use compared to traditional shelf-stable pills?
How must clinical trial frameworks adapt to evaluate therapies that are inherently personalized (tailored to a specific patient’s bacterial strain) rather than mass-produced?
Given historical and public anxieties surrounding the word “virus,” how can public health officials ethically communicate the safety and efficacy of viral therapies?

Materials Science

For billions of years, nature has perfected the art of molecular engineering, producing materials with extraordinary properties like the lightweight toughness and shine of abalone nacre, the self-cleaning properties of the lotus leaf, and the tensile strength of spider silk. While materials scientists can successfully replicate these structures on a microscopic scale in a laboratory, translating these complex designs into industrial goods is a different challenge entirely. Traditional manufacturing techniques like injection molding and extrusion are not suited for the intricate, bottom-up assembly characteristic of these biomimetic materials, meaning the materials industry must reevaluate how to scale these potentially paradigm-shifting materials.

How should material scientists bridge the gap between biomimetic materials and industrial manufacturing and what role should these materials play in the global market?

Here are some questions to help guide your writing:

What specific structural or molecular features make natural materials (like bone, silk, or gecko adhesives) so difficult to replicate using traditional manufacturing methods?
What advanced fabrication technologies, such as high-resolution 3D bioprinting or directed self-assembly, show the most promise for scaling up biomimetic production?
From an environmental standpoint, how does the lifecycle and biodegradability of biomimetic materials compare to conventional synthetic polymers and petroleum-based plastics?
How might the widespread commercialization of biomimetic materials disrupt global supply chains and manufacturing economies that rely heavily on traditional metallurgy and plastics?
How can researchers balance the desire to perfectly mimic nature’s complexity with the practical economic need for cost-effective, high-throughput industrial output?

Agriculture

Seafood is a globally demanded commodity, but over 90% of the world’s marine fish stocks are fully exploited or depleted. Traditional aquaculture (fish farming) was originally pitched as a solution to this, but it has endured criticism for habitat destruction, antibiotic overuse, and pollution. A potential solution has now emerged called cellular aquaculture, which is the process of growing genuine seafood directly from fish cells in bioreactors. This now means that companies can cultivate everything from salmon fillets to bluefin tuna without even catching a single fish, potentially creating massive disruption within the food industry affecting coastal economies, global supply chains, and marine conservation.

Can cellular aquaculture successfully replace traditional fishing methods, and what are the ecological trade-offs of shifting to lab-grown oceans?

Here are some questions to help guide your writing:

How does the biotechnology behind cell-cultured seafood differ from plant-based meat alternatives, and what are the primary scaling bottlenecks?
What are the immediate and long-term environmental benefits of lab-grown seafood compared to both wild-capture fisheries and traditional open-pen aquaculture?
How might a widespread shift to cellular agriculture economically impact traditional fishing communities and developing nations that rely on this economy?
What safety, regulatory, and labeling hurdles must cell-cultured seafood overcome before achieving widespread consumer trust and adoption?
From a lifecycle analysis perspective, how do the energy and carbon footprints of running industrial bioreactors compare to the carbon footprint of traditional fishing fleets?